This inventor holds 1 USPTO granted patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1987
Title: **The Innovative Mind of Masami Saitou**
Introduction
Masami Saitou, a notable inventor based in Kanagawa, Japan, is recognized for his significant contribution to the field of organic chemistry. With a focus on benzoic acid derivatives, Saitou's research has opened up new avenues for infection control agents.
Latest Patents
Saitou holds one patent that introduces innovative benzoic acid derivatives. The patent encompasses a specific formula wherein n is an integer between 0 and 2; R1 to R3 can represent a range of elements including hydrogen, halogen, lower alkyl groups, lower alkoxy groups, or nitro groups. Moreover, R4 can be either a hydroxyl group or a derivative group, showcasing the diversity and potential application of these compounds as infection control agents. Notably, the patented compounds were first synthesized under Saitou's invention, marking them as unique in their chemical structure.
Career Highlights
Masami Saitou is employed at Chugai Seiyaku Kabushiki Kaisha, a prominent pharmaceutical company in Japan. His work has been pivotal in advancing the field of medicinal chemistry, leading to innovative solutions that address pressing health challenges.
Collaborations
Throughout his career, Saitou has collaborated with esteemed colleagues, including Mitsuru Tanemura and female inventor Isao Matsunaga. This collaborative spirit has fostered an environment where innovative ideas can flourish, bringing forth advancements in research and development.
Conclusion
Masami Saitou’s contributions, particularly through his patent on benzoic acid derivatives, highlight the important intersection of innovation and practical application in medical research. His work at Chugai Seiyaku Kabushiki Kaisha, along with productive collaborations, continues to pave the way for future advancements in infection control technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
